Optimal treatment of social phobia: systematic review and meta-analysis

John Canton, Kate M Scott, Paul GlueDepartment of Psychological Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New ZealandAbstract: This article proposes a number of recommendations for the treatment of generalized social phobia, based on a systematic literature review and meta-...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Scott KM, Canton J, Glue P
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/40f3a2b178e145b0a816ad62c4bcc7a4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:40f3a2b178e145b0a816ad62c4bcc7a4
record_format	dspace
spelling	oai:doaj.org-article:40f3a2b178e145b0a816ad62c4bcc7a42021-12-02T01:17:39ZOptimal treatment of social phobia: systematic review and meta-analysis1176-63281178-2021https://doaj.org/article/40f3a2b178e145b0a816ad62c4bcc7a42012-05-01T00:00:00Zhttp://www.dovepress.com/optimal-treatment-of-social-phobia-systematic-review-and-meta-analysis-a9819https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021John Canton, Kate M Scott, Paul GlueDepartment of Psychological Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New ZealandAbstract: This article proposes a number of recommendations for the treatment of generalized social phobia, based on a systematic literature review and meta-analysis. An optimal treatment regimen would include a combination of medication and psychotherapy, along with an assertive clinical management program. For medications, selective serotonin reuptake inhibitors and dual serotonin-norepinephrine reuptake inhibitors are first-line choices based on their efficacy and tolerability profiles. The nonselective monoamine oxidase inhibitor, phenelzine, may be more potent than these two drug classes, but because of its food and drug interaction liabilities, its use should be restricted to patients not responding to selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors. There are other medication classes with demonstrated efficacy in social phobia (benzodiazepines, antipsychotics, alpha-2-delta ligands), but due to limited published clinical trial data and the potential for dependence and withdrawal issues with benzodiazepines, it is unclear how best to incorporate these drugs into treatment regimens. There are very few clinical trials on the use of combined medications. Cognitive behavior therapy appears to be more effective than other evidence-based psychological techniques, and its effects appear to be more enduring than those of pharmacotherapy. There is some evidence, albeit limited to certain drug classes, that the combination of medication and cognitive behavior therapy may be more effective than either strategy used alone. Generalized social phobia is a chronic disorder, and many patients will require long-term support and treatment.Keywords: social phobia, social anxiety disorder, psychotherapy, cognitive behavior therapy, antidepressantScott KMCanton JGlue PDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2012, Iss default, Pp 203-215 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Scott KM Canton J Glue P Optimal treatment of social phobia: systematic review and meta-analysis
description	John Canton, Kate M Scott, Paul GlueDepartment of Psychological Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New ZealandAbstract: This article proposes a number of recommendations for the treatment of generalized social phobia, based on a systematic literature review and meta-analysis. An optimal treatment regimen would include a combination of medication and psychotherapy, along with an assertive clinical management program. For medications, selective serotonin reuptake inhibitors and dual serotonin-norepinephrine reuptake inhibitors are first-line choices based on their efficacy and tolerability profiles. The nonselective monoamine oxidase inhibitor, phenelzine, may be more potent than these two drug classes, but because of its food and drug interaction liabilities, its use should be restricted to patients not responding to selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors. There are other medication classes with demonstrated efficacy in social phobia (benzodiazepines, antipsychotics, alpha-2-delta ligands), but due to limited published clinical trial data and the potential for dependence and withdrawal issues with benzodiazepines, it is unclear how best to incorporate these drugs into treatment regimens. There are very few clinical trials on the use of combined medications. Cognitive behavior therapy appears to be more effective than other evidence-based psychological techniques, and its effects appear to be more enduring than those of pharmacotherapy. There is some evidence, albeit limited to certain drug classes, that the combination of medication and cognitive behavior therapy may be more effective than either strategy used alone. Generalized social phobia is a chronic disorder, and many patients will require long-term support and treatment.Keywords: social phobia, social anxiety disorder, psychotherapy, cognitive behavior therapy, antidepressant
format	article
author	Scott KM Canton J Glue P
author_facet	Scott KM Canton J Glue P
author_sort	Scott KM
title	Optimal treatment of social phobia: systematic review and meta-analysis
title_short	Optimal treatment of social phobia: systematic review and meta-analysis
title_full	Optimal treatment of social phobia: systematic review and meta-analysis
title_fullStr	Optimal treatment of social phobia: systematic review and meta-analysis
title_full_unstemmed	Optimal treatment of social phobia: systematic review and meta-analysis
title_sort	optimal treatment of social phobia: systematic review and meta-analysis
publisher	Dove Medical Press
publishDate	2012
url	https://doaj.org/article/40f3a2b178e145b0a816ad62c4bcc7a4
work_keys_str_mv	AT scottkm optimaltreatmentofsocialphobiasystematicreviewandmetaanalysis AT cantonj optimaltreatmentofsocialphobiasystematicreviewandmetaanalysis AT gluep optimaltreatmentofsocialphobiasystematicreviewandmetaanalysis
_version_	1718403134338891776

Optimal treatment of social phobia: systematic review and meta-analysis

Ejemplares similares